<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pozzi C</submitter><funding>Fondazione AIRC per la ricerca sul cancro ETS (AIRC)</funding><funding>Fondazione AIRC per la ricerca sul cancro ETS</funding><pagination>2215-2232</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12423316</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(9)</volume><pubmed_abstract>Identification of biomarkers for the hematogenous spreading of cancer cells is of paramount prognostic and therapeutic value. We showed that Plasmalemma Vesicle Associated Protein-1 (PV-1) serves as a marker of increased blood vessel permeability and is an independent predictor of colorectal cancer dissemination. This study investigates whether PV-1 can also act as a prognostic marker for distant metastases in other solid tumors. We analyzed samples from 134 patients: 30 luminal breast cancer (BC), 52 clear cell renal cell carcinoma (ccRCC), and obtained preliminary data from 52 soft tissue sarcomas (STS). A higher frequency of PV-1+ endothelial cells was significantly associated with metastatic progression in luminal BC and ccRCC. Moreover, the frequency of PV-1+ cells emerged as a signif</pubmed_abstract><journal>EMBO molecular medicine</journal><pubmed_title>PV-1: a novel molecular prognostic marker of distant metastases in various solid tumors.</pubmed_title><pmcid>PMC12423316</pmcid><funding_grant_id>5x1000 2018 ID.21147</funding_grant_id><funding_grant_id>5x1000 2019 ID.22757</funding_grant_id><pubmed_authors>Renne SL</pubmed_authors><pubmed_authors>Cananzi FCM</pubmed_authors><pubmed_authors>Pozzi C</pubmed_authors><pubmed_authors>Diana P</pubmed_authors><pubmed_authors>Sama L</pubmed_authors><pubmed_authors>Sarti R</pubmed_authors><pubmed_authors>Lo Cascio A</pubmed_authors><pubmed_authors>Bertuzzi A</pubmed_authors><pubmed_authors>Bonovas S</pubmed_authors><pubmed_authors>Lizier M</pubmed_authors><pubmed_authors>Tiraboschi L</pubmed_authors><pubmed_authors>Rescigno M</pubmed_authors><pubmed_authors>Fernandes B</pubmed_authors><pubmed_authors>Bertocchi A</pubmed_authors><pubmed_authors>Torrisi R</pubmed_authors><pubmed_authors>Tinterri C</pubmed_authors><pubmed_authors>Valeri M</pubmed_authors><pubmed_authors>Lazzeri M</pubmed_authors><pubmed_authors>Mazza EMC</pubmed_authors><pubmed_authors>Colombo P</pubmed_authors></additional><is_claimable>false</is_claimable><name>PV-1: a novel molecular prognostic marker of distant metastases in various solid tumors.</name><description>Identification of biomarkers for the hematogenous spreading of cancer cells is of paramount prognostic and therapeutic value. We showed that Plasmalemma Vesicle Associated Protein-1 (PV-1) serves as a marker of increased blood vessel permeability and is an independent predictor of colorectal cancer dissemination. This study investigates whether PV-1 can also act as a prognostic marker for distant metastases in other solid tumors. We analyzed samples from 134 patients: 30 luminal breast cancer (BC), 52 clear cell renal cell carcinoma (ccRCC), and obtained preliminary data from 52 soft tissue sarcomas (STS). A higher frequency of PV-1+ endothelial cells was significantly associated with metastatic progression in luminal BC and ccRCC. Moreover, the frequency of PV-1+ cells emerged as a signif</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-03T02:28:10.344Z</modification><creation>2026-04-23T03:10:44.923Z</creation></dates><accession>S-EPMC12423316</accession><cross_references><pubmed>40691302</pubmed><doi>10.1038/s44321-025-00277-5</doi></cross_references></HashMap>